Imidazolone and imidazoloidinone derivatives as 11b-HSD1 inhibitors
US8129423B2 · kind B2 · utility
6Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2007 |
| Grant date | Mar 6, 2012 |
| Priority date | — |
| Expiry date | Jun 2, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formulaas well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.